Tramadol Hydrochloride

盐酸曲马多

Report date: 2023/04/25 15:42:44
NME

Base Information

Drug NameTramadol Hydrochloride
Drug Alias Name盐酸曲马朵Tramadol extended release - e-Therapeutics曲马多Tramadol sustained release - e-TherapeuticsZertane +[56] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMu opioid receptor agonists
TargetsMu opioid receptor
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)ContraceptionSubstance Withdrawal Syndrome +[17] 
Global Approved IndicationsPain
Approved Indications in ChinaPain
Original Approved Country/TerritoryGermany
Original Approved Date1973/01/01
Country/TerritoryCzechiaBelgiumBulgaria +[20] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesUnither Pharmaceuticals, FranceSindh Institute of Urology and TransplantationJohnson & Johnson +[4] 
Inactive CompaniesFederal University Of Sao PauloCairo UniversityImam Abdulrahman Bin Faisal University +[15] 
Active IndicationsPainChills
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)ContraceptionSubstance Withdrawal Syndrome +[15] 

Other Information

ATC CodeN02AX02
Related LinksWikipediaDrugBankKEGG